Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
3b blackbio dx limited stock

3B BlackBio Dx Limited Share Price

1695 -3.34 (-0.19%)
Nov 21 2024 03:29 PM Healthcare NSE: 3BBLACKBIO

3B BlackBio Dx Limited Share Price Update

As of the latest trading session, 3B BlackBio Dx Limited share price is currently at 1695, which is down by -3.34 from its previous closing. Today, the stock has fluctuated between 1675.00 and 1765.00. Over the past year, 3B BlackBio Dx Limited has achieved a return of 135.26 %. In the last month alone, the return has been 22.28 %. Read More...

3B BlackBio Dx Limited Performance

Day Range

Low1675.00 High1765.00
1690.70

52 Week Range

Low 660.00 High 1910.00
1690.70

3B BlackBio Dx Limited Share Price

532067

3BBLACKBIO

img img img img
No Data Available

Open Price

1695.00

Prev. Close

1698.35

Volume (Shares)

7962.00

Total traded value

135.57

Upper Circuit

2038.00

Lower Circuit

1358.70

Note: The current prices & values are delayed, Login to your account for live updates.

3B BlackBio Dx Limited Fundamentals


(Standalone)

Market Cap (Cr) 1454.76
PE Ratio (TTM) 33.63
Book Value / Share 291.40
Beta 0.36
ROE 16.14%
EPS (TTM) 50.27
Dividend Yield 0.18%
Net Profit Qtr (Cr) 14.14

3B BlackBio Dx Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 26.57
Operating Expense 11.72
Net Profit 14.14
Net Profit Margin (%) 53.21
Earnings Per Share (EPS) 16.51
EBITDA 18.52
Effective Tax Rate (%) 22.60
Particulars JUN 2024 (Values in Cr)
Revenue 17.51
Operating Expense 7.39
Net Profit 10.73
Net Profit Margin (%) 61.27
Earnings Per Share (EPS) 12.53
EBITDA 14.02
Effective Tax Rate (%) 22.18
Particulars MAR 2024 (Values in Cr)
Revenue 21.99
Operating Expense 12.13
Net Profit 9.06
Net Profit Margin (%) 41.20
Earnings Per Share (EPS) 10.57
EBITDA 14.30
Effective Tax Rate (%) 35.28
Particulars DEC 2023 (Values in Cr)
Revenue 16.96
Operating Expense 7.57
Net Profit 9.21
Net Profit Margin (%) 54.30
Earnings Per Share (EPS) 10.75
EBITDA 12.05
Effective Tax Rate (%) 22.29
Particulars SEP 2023 (Values in Cr)
Revenue 18.57
Operating Expense 10.17
Net Profit 8.48
Net Profit Margin (%) 45.66
Earnings Per Share (EPS) 9.90
EBITDA 11.41
Effective Tax Rate (%) 23.94
Particulars MAR 2024 (Values in Cr)
Revenue 70.72
Operating Expense 36.58
Net Profit 34.21
Net Profit Margin (%) 48.37
Earnings Per Share (EPS) 39.93
EBITDA 47.41
Effective Tax Rate (%) 26.33
Particulars MAR 2023 (Values in Cr)
Revenue 59.34
Operating Expense 30.75
Net Profit 26.42
Net Profit Margin (%) 44.52
Earnings Per Share (EPS) 35.27
EBITDA 36.84
Effective Tax Rate (%) 26.28
Particulars MAR 2022 (Values in Cr)
Revenue 15.52
Operating Expense 17.16
Net Profit 8.01
Net Profit Margin (%) 51.61
Earnings Per Share (EPS) 10.67
EBITDA 8.86
Effective Tax Rate (%) 5.43
Particulars MAR 2021 (Values in Cr)
Revenue 14.36
Operating Expense 16.00
Net Profit 1.72
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 2.29
EBITDA 2.51
Effective Tax Rate (%) 17.78
Particulars MAR 2020 (Values in Cr)
Revenue 13.51
Operating Expense 14.30
Net Profit 0.61
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 0.82
EBITDA 1.16
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 260.32
ROE % 15.42
ROCE % 21.20
Total Debt to Total Equity 0.01
EBITDA Margin 61.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share 225.60
ROE % 14.98
ROCE % 20.24
Total Debt to Total Equity 0.01
EBITDA Margin 58.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 204.26
ROE % 22.59
ROCE % 29.92
Total Debt to Total Equity 0.02
EBITDA Margin 54.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 176.27
ROE % 138.73
ROCE % 179.45
Total Debt to Total Equity 0.03
EBITDA Margin 67.43
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.87
ROE % 28.16
ROCE % 32.28
Total Debt to Total Equity 0.18
EBITDA Margin 37.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 265.84
ROE % 16.14
ROCE % 21.82
Total Debt to Total Equity 0.01
EBITDA Margin 67.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 228.91
ROE % 24.01
ROCE % 32.09
Total Debt to Total Equity 0.02
EBITDA Margin 62.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.94
ROE % 34.39
ROCE % 33.57
Total Debt to Total Equity 0.10
EBITDA Margin 57.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.24
ROE % 7.92
ROCE % 9.48
Total Debt to Total Equity 0.13
EBITDA Margin 17.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.74
ROE % 3.34
ROCE % 4.07
Total Debt to Total Equity 0.27
EBITDA Margin 8.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 62.14
Total Assets 248.10
Total Liabilities 248.10
Total Equity 225.47
Share Outstanding 8582670
Price to Book Ratio 2.89
Return on Assets (%) 12.93
Return on Capital (%) 14.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 59.20
Total Assets 214.05
Total Liabilities 214.05
Total Equity 195.91
Share Outstanding 8582670
Price to Book Ratio 1.82
Return on Assets (%) 12.11
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.89
Total Assets 192.09
Total Liabilities 192.09
Total Equity 172.07
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 16.76
Return on Capital (%) 18.44
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 35.07
Total Assets 193.52
Total Liabilities 193.52
Total Equity 148.27
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 58.83
Return on Capital (%) 75.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.38
Total Assets 44.83
Total Liabilities 44.83
Total Equity 34.25
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 17.14
Return on Capital (%) 20.35
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 54.87
Total Assets 249.82
Total Liabilities 249.82
Total Equity 227.78
Share Outstanding 8582670
Price to Book Ratio 2.89
Return on Assets (%) 13.69
Return on Capital (%) 14.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 50.35
Total Assets 213.66
Total Liabilities 213.66
Total Equity 196.09
Share Outstanding 8582670
Price to Book Ratio 1.82
Return on Assets (%) 12.36
Return on Capital (%) 13.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 31.60
Total Liabilities 31.60
Total Equity 23.92
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 25.33
Return on Capital (%) 30.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.70
Total Assets 28.88
Total Liabilities 28.88
Total Equity 22.65
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 5.94
Return on Capital (%) 6.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 28.16
Total Liabilities 28.16
Total Equity 20.78
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 2.17
Return on Capital (%) 2.53
Particulars MAR 2024 (Values in Cr)
Net Income 44.33
Cash from Operations 37.79
Cash from Investing -20.31
Cash from Financing -3.62
Net change in Cash 3.00
Free Cash Flow 38.29
Particulars MAR 2023 (Values in Cr)
Net Income 35.30
Cash from Operations 29.22
Cash from Investing 14.73
Cash from Financing -5.00
Net change in Cash 30.01
Free Cash Flow 31.25
Particulars MAR 2022 (Values in Cr)
Net Income 43.22
Cash from Operations 47.88
Cash from Investing -28.44
Cash from Financing -15.07
Net change in Cash -6.18
Free Cash Flow 50.15
Particulars MAR 2021 (Values in Cr)
Net Income 152.03
Cash from Operations 135.40
Cash from Investing -70.25
Cash from Financing -1.56
Net change in Cash 25.69
Free Cash Flow 137.08
Particulars MAR 2020 (Values in Cr)
Net Income 10.04
Cash from Operations 9.45
Cash from Investing -0.63
Cash from Financing 0.80
Net change in Cash 7.21
Free Cash Flow 9.98
Particulars MAR 2024 (Values in Cr)
Net Income 46.44
Cash from Operations 39.30
Cash from Investing -20.31
Cash from Financing -3.61
Net change in Cash 4.52
Free Cash Flow 39.81
Particulars MAR 2023 (Values in Cr)
Net Income 35.84
Cash from Operations 30.14
Cash from Investing -7.80
Cash from Financing -2.89
Net change in Cash 10.46
Free Cash Flow 31.10
Particulars MAR 2022 (Values in Cr)
Net Income 8.46
Cash from Operations 8.14
Cash from Investing -1.52
Cash from Financing -6.30
Net change in Cash 0.14
Free Cash Flow 9.66
Particulars MAR 2021 (Values in Cr)
Net Income 2.08
Cash from Operations 3.18
Cash from Investing -0.17
Cash from Financing -1.59
Net change in Cash 1.02
Free Cash Flow 3.33
Particulars MAR 2020 (Values in Cr)
Net Income 0.61
Cash from Operations 1.10
Cash from Investing -2.45
Cash from Financing 1.42
Net change in Cash 0.07
Free Cash Flow 1.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 81.21 12.82 96071.16 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.50 0.00 3.36 100.27 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 114.95 / 316.85
TRANSGENE BIOTEK LTD. 6.73 0.00 4.70 50.99 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 85.55 11.72 96071.16 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.70 0.00 -20.73 28.91 28.42 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5335.90 28.94 5.99 5837.47 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1613.40
  • 26 Days 1463.60
  • 10 Days 1550.60
  • 50 Days 1431.30
  • 12 Days 1533.80
  • 100 Days 1343.50
  • 20 Days 1485.90
  • 200 Days 898.70
1696.45
PIVOT
First Resistance 1742.90
Second Resistance 1805.35
Third Resistance 1851.80
First Support 1634.00
Second Support 1587.55
Third Support 1525.10
RSI 70.67
MACD 70.18
Commodity Channel Index (CCI) 188.41
ADX 20.72
Williams % R -34.22

Over 1 Month

down

22.28

Over 3 Months

down

16.80

Over 6 Months

down

106.86

Over 1 Year

down

135.26

Over 3 Years

down

60.43

Over 5 Years

down

81.53

3B BlackBio Dx Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

3B BlackBio Dx Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
55.44
Promoter Holdings
41.28
FII
3.26
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Mithla Dubey Shareholding of Promoter and Promoter Group 1059770.0 12.35
Mithala Laboratories Private Limited Shareholding of Promoter and Promoter Group 820700.0 9.56
Dhirendra Dubey Shareholding of Promoter and Promoter Group 724098.0 8.44
Varun Daga Public Shareholding 450000.0 5.24
Prateek Goel Public Shareholding 444435.0 5.18
Own Infracon Private Limited Public Shareholding 422664.0 4.92
Nikhil Kuber Dubey Shareholding of Promoter and Promoter Group 358080.0 4.17
2b Blackbio S.l. Spain Shareholding of Promoter and Promoter Group 241570.0 2.81
Maj Navraj Singh Grewal Public Shareholding 224400.0 2.61
Ark Global Emerging Companies Lp Public Shareholding 202829.0 2.36
Ram Kuber Dhirendra Kumar Shareholding of Promoter and Promoter Group 194700.0 2.27
Dalmus Performance Focused Fund Public Shareholding 141167.0 1.64
Shalu Aggarwal Public Shareholding 89729.0 1.05
Sandeep Kapadia Public Shareholding 86000.0 1.0
Rajesh Kumar Dubey Shareholding of Promoter and Promoter Group 37700.0 0.44
Madhulika Dubey Shareholding of Promoter and Promoter Group 29000.0 0.34
Santosh Kumar Dubey Shareholding of Promoter and Promoter Group 26200.0 0.31
Mahesh Kumar Upadhyay Shareholding of Promoter and Promoter Group 24500.0 0.29
Anamika Dubey Shareholding of Promoter and Promoter Group 22000.0 0.26
Sanjay Kumar Dubey Shareholding of Promoter and Promoter Group 5100.0 0.06

3B BlackBio Dx Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 2.5 Final 2023-09-15 Equity shares 2022-09-14 2.5 Final 2022-09-16 Equity shares 2021-09-14 1.0 Final 2021-09-16 Equity shares 2021-09-14 8.0 Special 2021-09-16 Equity shares 2020-03-19 0.7 Interim 2020-03-20 Equity shares 2019-09-17 0.5 Final 2019-09-19 Equity shares 2018-09-17 0.5 Final 2018-09-19 Equity shares 2017-09-15 0.3 Final 2017-09-19 Equity shares 2011-09-19 1.0 Final 2011-09-21 Equity shares 2007-09-18 1.0 Final 2007-09-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About 3B BlackBio Dx Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by 3B BlackBio Dx Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of 3B Blackbio DX Ltd?

Answer Field

The share price of 3B Blackbio DX Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1690.70.

What is the Market Cap of 3B Blackbio DX Ltd?

Answer Field

The market cap of 3B Blackbio DX Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 14,51.10 Cr. as of now.

What is the 52 Week High and Low of 3B Blackbio DX Ltd?

Answer Field

The 52 Week High and Low of 3B Blackbio DX Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1910.00 and ₹ 660.00.

How to Buy 3B Blackbio DX Ltd share?

Answer Field

You can trade in 3B Blackbio DX Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for 3B Blackbio DX Ltd?

Answer Field

The 1 year returns on the stock has been 135.26%.

What is the Current Share Price of 3B Blackbio DX Ltd?

Answer Field

3B Blackbio DX Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1690.70 as on Nov 21 2024 03:29 PM.

What is the Market Cap of 3B Blackbio DX Ltd Share?

Answer Field

The market cap of 3B Blackbio DX Ltd for NSE ₹ 0.0 & for BSE ₹ 14,51.10 as on Nov 21 2024 03:29 PM.

What is the P/E Ratio of 3B Blackbio DX Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM the price-to-earnings (PE) ratio for 3B Blackbio DX Ltd share is 33.63.

What is the PB ratio of 3B Blackbio DX Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM, the price-to-book (PB) ratio for 3B Blackbio DX Ltd share is 291.40.

How to Buy 3B Blackbio DX Ltd Share?

Answer Field

You can trade in 3B Blackbio DX Ltd shares with Bajaj Broking by opening a demat account.

How to Buy 3B Blackbio DX Ltd Share on Bajaj Broking App?

Answer Field

To buy 3B Blackbio DX Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “3B Blackbio DX Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader